Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)

10.77 -1.02 (-8.65%)
Streaming Delayed Price Updated: 11:11 AM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,397,369
Open 11.01
Bid (Size) 10.77 (200)
Ask (Size) 10.78 (100)
Prev. Close 11.79
Today's Range 10.53 - 11.40
52wk Range 1.030 - 12.11
Shares Outstanding 88,406,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader
The first week of 2026 has set the biotech sector ablaze, with Revolution Medicines (NASDAQ: RVMD) finding itself at the epicenter of a high-stakes acquisition tug-of-war. Shares of the Redwood... 
Via MarketMinute
Topics Intellectual Property
News headline image
TANGO THERAPEUTICS INC (NASDAQ:TNGX) Posts Strong Q3 Earnings Beat Amid Mixed Market Reaction ↗
Tango Therapeutics (TNGX) reported a strong Q3, beating revenue and EPS estimates. Despite the earnings beat, the stock saw mixed market reaction. 
Via Chartmill
Topics Earnings

Performance

YTD
+20.6%
+20.6%
1 Month
+12.2%
+12.2%
3 Month
+55.9%
+55.9%
6 Month
+78.3%
+78.3%
1 Year
+210.4%
+210.4%

More News

Read More
News headline image
Earnings Scheduled For November 4, 2025 ↗
Via Benzinga
News headline image
A Peek at Tango Therapeutics's Future Earnings ↗
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
Via Benzinga
News headline image
Earnings Scheduled For May 12, 2025 ↗
Via Benzinga
News headline image
Insights into Tango Therapeutics's Upcoming Earnings ↗
Via Benzinga
News headline image
Unveiling 5 Analyst Insights On Tango Therapeutics ↗
Via Benzinga
News headline image
The Analyst Landscape: 5 Takes On Tango Therapeutics ↗
Via Benzinga
News headline image
Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement ↗
Via Benzinga
News headline image
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
Tango (TNGX) Q2 Revenue Drops 52% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Tango Therapeutics Inc (NASDAQ:TNGX) Reports Q2 2025 Earnings: Revenue Misses, EPS Meets Expectations Amid Clinical Progress ↗
Via Chartmill
News headline image
5 Biotech Stocks with Highly Anticipated Pending Results ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Quanex Building Products, Manchester United, Byrna Technologies And Other Big Stocks Moving Higher On Friday ↗
Via Benzinga
News headline image
What's going on in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Monday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Tango Therapeutics, Inc.
Via Business Wire
News headline image
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
From Tango Therapeutics, Inc.
Via Business Wire

Frequently Asked Questions

Is Tango Therapeutics, Inc. - Common Stock publicly traded?
Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Tango Therapeutics, Inc. - Common Stock trade on?
Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?
The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market
What is the current price of Tango Therapeutics, Inc. - Common Stock?
The current price of Tango Therapeutics, Inc. - Common Stock is 10.77
When was Tango Therapeutics, Inc. - Common Stock last traded?
The last trade of Tango Therapeutics, Inc. - Common Stock was at 01/08/26 11:11 AM ET
What is the market capitalization of Tango Therapeutics, Inc. - Common Stock?
The market capitalization of Tango Therapeutics, Inc. - Common Stock is 952.14M
How many shares of Tango Therapeutics, Inc. - Common Stock are outstanding?
Tango Therapeutics, Inc. - Common Stock has 952M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.